ZYDUSLIFE.BO

Zydus Lifesciences Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,096.00

-2.31%Jun 24, 2026

AI Brief

Market cap

$1.12T

52w range

—

P / E

—

P/S 4.1×

EPS · FY 2026

$50.09

Volume

—

Revenue · FY 2026

$271.48B

+16.81% YoY

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Zydus Lifesciences Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1096.00

Change

+12.42%

Period high

$1112.10

Period low

$860.55

Period start

$974.952025-06-25

Through 2026-06-24

Fair value

Football field →

Weighted blend

$1,291.58

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

ZYDUSLIFE.BO

1,096+12.42%

H 1,126L 835.85MA50 1,011MA200 956.49Avg vol 43K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Jun 2025	$65.74B	$14.67B	$14.58

Sector & industry today

Live

Sectors

Consumer Cyclical
+1.37%
Technology
+1.17%
Utilities
+0.96%
Financial Services
+0.65%
Basic Materials
+0.59%
Industrials
+0.54%
Consumer Defensive
+0.42%
Energy
-0.18%
Communication Services
-0.40%
Healthcare
-0.41%
Real Estate
-0.54%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+1.29%
Biotechnology
+9.63%
Software - Services
-7.11%
Business Equipment & Supplies
+6.51%
Financial - Mortgages
+4.52%
Furnishings, Fixtures & Appliances
+4.34%
Home Improvement
+3.89%
Construction
+3.62%
Paper, Lumber & Forest Products
+3.53%
Discount Stores
+3.53%
Medical - Diagnostics & Research
+3.31%
Financial - Conglomerates
+3.03%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for ZYDUSLIFE.BO.

Financial scores

DBJun 25, 2026

Altman Z

3.79

Safe

≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress

Piotroski F

2/9

Weak

≥ 7 strong · 4–6 average · < 4 weak

Peers

No peer list available for ZYDUSLIFE.BO.

Total assets

$524.07B

Total debt

$124.96B

Cash & equiv

$14.17B

Operating CF

$21.91B

Free cash flow

-$12.03B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$271.48B	$57.87B	$50.4B	$50.09	+18.56%
FY 2025	$232.42B	$96.04B	$45.26B	$44.97	+19.47%
FY 2024	$195.47B	$75.96B	$38.6B	$37.91	+19.74%